


| Key | % Net Assets |
|---|---|
| 7.4% | |
| 6.3% | |
| 5.9% | |
| 4.7% | |
| 75.7% |
| Name | % Net Assets |
|---|---|
| HSBC HLDGS | 7.4% |
| BP | 6.3% |
| GlaxoSmithKline | 5.9% |
| ROYAL DUTCH SHELL | 4.7% |
| VODAFONE GROUP | 4.1% |
| ROYAL BANK OF SCOTLAND GROUP PLC | 3.8% |
| ASTRAZENECA | 3.7% |
| ROYAL DUTCH SHELL | 3.5% |
| BARCLAYS | 2.9% |
| HBOS | 2.6% |
No asset data available.
| Date | 20-Aug-2025 |
|---|---|
| Bid | 595.80p |
| Offer | 595.80p |
| Currency | GBP |
| Change | 2.10p |
| % | 0.35% |
| YTD change | 78.40p |
| YTD % | 15.15% |
| Fund Inception | 01/05/1995 |
|---|---|
| Fund Manager | Barclays Global Investors |
| TER | 0.60 (19-Feb-2014) |
| Minimum Investment | |
|---|---|
| Initial | £100 |
| Additional | £100 |
| Savings | £25 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.04 |
You are here: research